Core Scientific (CORZ)
Nasdaq Market Closed
Core Scientific, Inc. is a digital infrastructure company that operates large-scale facilities for bitcoin mining, high-density computing, and related colocation services. The company designs, builds, and manages data centre campuses with access to substantial electrical capacity, making power procurement, facility uptime, cooling, and fleet management central to its business model.
Core Scientific’s largest revenue source has historically been digital asset self-mining. In this segment, the company runs mining equipment for its own account and earns bitcoin rewards and transaction fees from participating in the Bitcoin network. Results in this business are closely tied to bitcoin prices, network difficulty, block reward economics, energy costs, and the efficiency of its mining fleet.
The company also provides hosted mining services for third parties. Under this model, customers place mining machines in Core Scientific facilities and pay for infrastructure, power, maintenance, and operational support. Hosting can provide a different revenue profile from self-mining because it is based more on service arrangements than direct exposure to mined digital assets, though it remains linked to the health of the mining industry.
A growing part of Core Scientific’s strategy is high-density colocation for artificial intelligence and high-performance computing workloads. These applications require significant power and specialized infrastructure, areas where the company’s experience operating energy-intensive facilities may be relevant. This positions Core Scientific at the intersection of cryptocurrency mining and the broader demand for compute capacity.
For investors, the company represents exposure to both bitcoin mining economics and the expanding market for power-rich data centre infrastructure.
Last updated
- Market Cap
- 9.2B
- P/E
- —
- P/FCF
- —
- P/S
- 25.92
- Enterprise Value
- 10.25B
- Sector
- —
- Industry
- —
- Address
- 838 WALKER ROAD, DOVER, DE, 19904
CRWV Deadline: BFA Law Urges CoreWeave, Inc. Investors with Losses to Act Before March 13 Securities Fraud Class Action Deadline Amid 16% Stock Decline
CoreWeave Stock Notice: CoreWeave, Inc. (NASDAQ:CRWV) Shares Sink 16% on Infrastructure Delays - Investors Urged to Contact BFA Law about the Securities Class Action
CRWV COURT DEADLINE: CoreWeave, Inc. Faces Securities Fraud Allegations Over Infrastructure Delays – BFA Law Notifies Investors of the March 13 Class Action Deadline
CoreWeave, Inc. (NASDAQ:CRWV) Accused of Securities Fraud after Stock Drops 16% – Contact BFA Law before March 13
CRWV STOCK ALERT: CoreWeave, Inc. Investors are Encouraged to Act before the Upcoming March 13 Deadline – Contact BFA Law if You Lost Money
INVESTOR ALERT: CoreWeave, Inc. (CRWV) Investors with Substantial Losses Have Opportunity to Lead the CoreWeave Class Action Lawsuit – RGRD Law
CLASS ACTION DEADLINE: CoreWeave, Inc. (NASDAQ:CRWV) Securities Class Action Deadline is March 13 – Investors Notified to Contact BFA Law about the Filed Lawsuit
CRWV LAWSUIT INFORMATION: Important CoreWeave, Inc. Securities Class Action Deadline Approaching for Investors seeking Recovery – Contact BFA Law by March 13
CoreWeave: Nvidia Partnership Illustrates Why AI Picks-and-Shovels Matter Most
What CoreWeave’s $9B Core Scientific Deal Means for Its Stock Price
Raytheon wins $1.2 billion contract for additional Patriot air, missile defense systems to Germany By Reuters - Investing.com
Bernstein is bullish on these two less-known Bitcoin mining stocks - Investing.com
TriplePoint Venture Growth: A Potential Opportunity
Here's how U.S. investors can position themselves for the sea change out of Japan, according to Bank of America and Citi
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 9.2B
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 10.25B
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- -7.04
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 25.92
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- -67.12
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 28.89
- EPS
- -0.98
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 16.04
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- -461.08M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 23.75%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -10.1%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- -1.57
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 0.52
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 0.52
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.38
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 16.04M
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 28.93
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 115.24M | 79.76M | 81.1M | 78.63M | 79.53M |
| Gross profit | 30.11M | 20.76M | 3.91M | 5.03M | 8.21M |
| Operating income | -297.28M | -87.07M | -80.52M | -51.92M | -47.03M |
| EBITDA | -13.65M | -56.75M | -54.52M | -27.76M | -27.3M |
| Net income | -342.44M | 190.52M | -144.88M | -13.27M | 448.88M |
| Basic EPS | -1.06 | 0.6 | -0.45 | -0.04 | 1.42 |
| Diluted EPS | -1.06 | 0.6 | -0.45 | -0.04 | 1.24 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 3.07B | 2.35B | 2.17B | 1.85B | 1.5B |
| Total liabilities | 4.38B | 3.31B | 3.42B | 3.04B | 1.8B |
| Total equity | -1.31B | -962.74M | -1.25B | -1.19B | -297.19M |
| Cash & equivalents | 1.01B | 311.38M | 453.44M | 581.35M | 697.94M |
| Current assets | 1.39B | 895.54M | 1.06B | 1B | 832.4M |
| Current liabilities | 2.66B | 781.4M | 669.86M | 562.72M | 195.51M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | 249.88M | 157.51M | 131.78M | 34M | -45.04M |
| Investing cash flow | -386.65M | -277.77M | -254.36M | -119.61M | -89.02M |
| Financing cash flow | 971.38M | -21.81M | -5.32M | -31.77M | -4.2M |
| Change in cash | 834.61M | -142.07M | -127.9M | -117.38M | -138.26M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 4 — Core Scientific, Inc./tx | View Filing | |
| edgar index | 3 — Core Scientific, Inc./tx | View Filing | |
| edgar index | 4 — Core Scientific, Inc./tx | View Filing | |
| edgar index | SCHEDULE 13G — Core Scientific, Inc./tx | View Filing | |
| edgar index | 8-K — Core Scientific, Inc./tx | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — DUCHENE TODD M | View Filing | |
| form 4 | Form 4 — Smith Stephen M | View Filing | |
| edgar index | 4 — Core Scientific, Inc./tx | View Filing | |
| edgar index | 4 — Core Scientific, Inc./tx | View Filing | |
| edgar index | 4 — Core Scientific, Inc./tx | View Filing | |
| form 4 | Form 4 — DUCHENE TODD M | View Filing | |
| form 4 | Form 4 — Nygaard James P Jr | View Filing | |
| form 4 | Form 4 — DUCHENE TODD M | View Filing | |
| form 4 | Form 4 — DUCHENE TODD M | View Filing | |
| edgar index | SCHEDULE 13G/A — Core Scientific, Inc./tx | View Filing | |
| edgar index | SCHEDULE 13G/A — Core Scientific, Inc./tx | View Filing | |
| edgar index | SCHEDULE 13G/A — Core Scientific, Inc./tx | View Filing | |
| edgar index | 8-K — Core Scientific, Inc./tx | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — Core Scientific, Inc./tx | View Filing | |
| edgar index | 3 — Core Scientific, Inc./tx | View Filing | |
| form 3 | Form 3 — Ray Jorge L. | View Filing | |
| form 4 | Form 4 — DUCHENE TODD M | View Filing | |
| form 4 | Form 4 — DUCHENE TODD M | View Filing | |
| edgar index | 4 — Core Scientific, Inc./tx | View Filing | |
| edgar index | 8-K — Core Scientific, Inc./tx | View Filing | |
| edgar index | 8-K — Core Scientific, Inc./tx | View Filing | |
| edgar index | 8-K — Core Scientific, Inc./tx | View Filing | |
| edgar index | 10-Q — Core Scientific, Inc./tx | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Core Scientific, Inc./tx | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — DUCHENE TODD M | View Filing | |
| form 4 | Form 4 — DUCHENE TODD M | View Filing | |
| edgar index | 4 — Core Scientific, Inc./tx | View Filing | |
| edgar index | SCHEDULE 13G — Core Scientific, Inc./tx | View Filing | |
| edgar index | 8-K — Core Scientific, Inc./tx | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — DUCHENE TODD M | View Filing | |
| edgar index | SCHEDULE 13D/A — Core Scientific, Inc./tx | View Filing | |
| edgar index | 4 — Core Scientific, Inc./tx | View Filing | |
| edgar index | 8-K — Core Scientific, Inc./tx | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — DUCHENE TODD M | View Filing | |
| edgar index | 4 — Core Scientific, Inc./tx | View Filing | |
| edgar index | 4 — Core Scientific, Inc./tx | View Filing | |
| edgar index | SCHEDULE 13D/A — Core Scientific, Inc./tx | View Filing | |
| form 4 | Form 4 — DUCHENE TODD M | View Filing | |
| edgar index | 4 — Core Scientific, Inc./tx | View Filing | |
| form 4 | Form 4 — Sullivan Adam Taylor | View Filing | |
| form 4 | Form 4 — DUCHENE TODD M | View Filing | |
| form 4 | Form 4 — DUCHENE TODD M | View Filing | |
| edgar index | 4 — Core Scientific, Inc./tx | View Filing | |
| form 4 | Form 4 — DUCHENE TODD M | View Filing | |
| edgar index | 4 — Core Scientific, Inc./tx | View Filing | |
| edgar index | 4 — Core Scientific, Inc./tx | View Filing | |
| edgar index | 144 — Core Scientific, Inc./tx | View Filing | |
| form 4 | Form 4 — DUCHENE TODD M | View Filing | |
| form 4 | Form 4 — DUCHENE TODD M | View Filing | |
| form 4 | Form 4 — DUCHENE TODD M | View Filing | |
| form 4 | Form 4 — Sullivan Adam Taylor | View Filing | |
| form 4 | Form 4 — Sullivan Adam Taylor | View Filing | |
| edgar index | 4/A — Core Scientific, Inc./tx | View Filing | |
| edgar index | SCHEDULE 13G/A — Core Scientific, Inc./tx | View Filing | |
| form 4 | Form 4 — Nygaard James P Jr | View Filing | |
| edgar index | 8-K — Core Scientific, Inc./tx | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13D/A — Core Scientific, Inc./tx | View Filing | |
| edgar index | 4 — Core Scientific, Inc./tx | View Filing | |
| edgar index | 10-K/A — Core Scientific, Inc./tx | View Filing | |
| form 4 | Form 4 — Nygaard James P Jr | View Filing | |
| edgar index | SCHEDULE 13G — Core Scientific, Inc./tx | View Filing |